Prognostic implications of the urinary albumin to creatinine ratio in veterans of different ages with diabetes

Archives of Internal Medicine

Volumn 170, Issue 11, 2010, Pages 930-936

  O'Hare, Ann M ^a   Hailpern, Susan M ^b   Pavkov, Meda E ^b   Rios Burrows, Nilka ^b   Gupta, Indra ^a   Maynard, Charles ^a   Todd Stenberg, Jeff ^a   Rodriguez, Rudolph A ^a   Hemmelgarn, Brenda R ^c   Saran, Rajiv ^d   Williams, Desmond E ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE;

AGE DISTRIBUTION; AGED; ALBUMINURIA; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH CARE SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MICROALBUMINURIA; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; URINALYSIS; VETERAN;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ALBUMINURIA; BIOLOGICAL MARKERS; CAUSE OF DEATH; CREATININE; DIABETES MELLITUS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; UNITED STATES; VETERANS; YOUNG ADULT;

EID: 77953723074     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2010.129     Document Type: Article

References (29)

1. Yuyun MF, Khaw KT, Luben R, et al; European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. Int J Epidemiol. 2004;33(1):189-198.
2. Romundstad S, Holmen J, Hallan H, Kvenild K, Ellekjaer H. Microalbuminuria and all-cause mortality in treated hypertensive individuals: does sex matter? the Nord-Trondelag Health Study (HUNT), Norway. Circulation. 2003;108(22):2783-2789.
3. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation. 2004;110(1):32-35. (Pubitemid 38880131)
4. Jager A, Kostense PJ, Ruhé HG, et al. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol. 1999;19(3):617-624. (Pubitemid 29135163)
5. Hillege HL, Janssen WM, Bak AA, et al; Prevend Study Group. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med. 2001;249(6):519-526.
6. Gerstein HC, Mann JF, Yi Q, et al; HOPE Study Investigators. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286(4):421-426.
7. Arnlöv J, Evans JC, Meigs JB, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation. 2005;112(7):969-975. (Pubitemid 41170264)
8. Wen CP, Cheng TY, Tsai MK, et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet. 2008;371(9631):2173-2182.
9. Hallan S, Astor B, Romundstad S, Aasarød K, Kvenild K, Coresh J. Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: the HUNT II Study. Arch Intern Med. 2007;167(22):2490-2496. (Pubitemid 350254909)
10. Tonelli M, Jose P, Curhan G, Sacks F, Braunwald E, Pfeffer M; Cholesterol and Recurrent Events (CARE) Trial Investigators. Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial. BMJ. 2006;332(7555):1426. doi:10.1136/bmj.38814.566019.2F.
11. Foster MC, Hwang SJ, Larson MG, et al. Cross-classification of microalbuminuria and reduced glomerular filtration rate: associations between cardiovascular disease risk factors and clinical outcomes. Arch Intern Med. 2007;167(13): 1386-1392.
12. Astor BC, Hallan SI, Miller ER III, Yeung E, Coresh J. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Am J Epidemiol. 2008;167(10):1226-1234. (Pubitemid 351670638)
13. So WY, Kong AP, Ma RC, et al. Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients. Diabetes Care. 2006;29(9): 2046-2052.
14. de Boer IH, Katz R, Cao JJ, et al. Cystatin C, albuminuria, and mortality among older adults with diabetes. Diabetes Care. 2009;32(10):1833-1838.
15. Bruno G, Merletti F, Bargero G, et al. Estimated glomerular filtration rate, albuminuria and mortality in type 2 diabetes: the Casale Monferrato study. Diabetologia. 2007;50(5):941-948. (Pubitemid 46559254)
16. Roderick PJ, Atkins RJ, Smeeth L, et al. CKD and mortality risk in older people: a community-based population study in the United Kingdom. Am J Kidney Dis. 2009;53(6):950-960.
17. Raymond NT, Zehnder D, Smith SC, Stinson JA, Lehnert H, Higgins RM. Elevated relative mortality risk with mild-to-moderate chronic kidney disease decreases with age. Nephrol Dial Transplant. 2007;22(11):3214-3220. (Pubitemid 350202561)
18. O'Hare AM, Bertenthal D, Covinsky KE, et al. Mortality risk stratification in chronic kidney disease: one size for all ages? J Am Soc Nephrol. 2006;17(3):846-853.
19. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17):2038-2047. (Pubitemid 350074801)
20. Conway B, Webster A, Ramsay G, et al. Predicting mortality and uptake of renal replacement therapy in patients with stage 4 chronic kidney disease. Nephrol Dial Transplant. 2009;24(6):1930-1937.
21. Current Procedural Terminology. Chicago, IL: American Medical Association; 2009.
22. Smith MW, Joseph GJ. Pharmacy data in the VA health care system. Med Care Res Rev. 2003;60(3)(suppl):92S-123S.
23. Arnold N, Sohn MW, Maynard C, Hynes DM. VIReC Technical Report 2: VA-NDI Mortality Data Merge Project. April 9, 2006. http://www.virec.research.va.gov/ References/TechnicalReports/TECH-REPORT2-NDI.pdf. Accessed September 4, 2009.
24. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D; Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130(6):461-470.
25. Arday SL, Arday DR, Monroe S, Zhang J. HCFA's racial and ethnic data: current accuracy and recent improvements. Health Care Financ Rev. 2000;21(4):107-116.
26. Sohn MW, Zhang H, Arnold N, et al. Transition to the new race/ethnicity data collection standards in the Department of Veterans Affairs. Popul Health Metr. 2006;4:7. doi:10.1186/1478-7954-4-7.
27. Hosmer DW, Lemershow S. Applied Survival Analysis. New York, NY: John Wiley & Sons; 1999.
28. Glassock RJ, Winearls C. An epidemic of chronic kidney disease: fact or fiction? Nephrol Dial Transplant. 2008;23(4):1117-1121.
29. Pavkov ME, Knowler WC, Hanson RL, Bennett PH, Nelson RG. Predictive power of sequential measures of albuminuria for progression to ESRD or death in Pima Indians with type 2 diabetes. Am J Kidney Dis. 2008;51(5):759-766.